Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION AND TREATMENT COMPRISING TUBULOSINE
Document Type and Number:
WIPO Patent Application WO/2018/093065
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for cancer treatment comprising tubulosine as an active ingredient. In the composition of the present invention, tubulosine inhibits the catalytic activity of a JAK in leukemia and lymphoma cell lines, thereby entirely and strongly inhibits structurally activated cytokine-induced JAK3 signaling, and thus can be usefully employed as a preparation for inhibiting the survival and proliferation of active JAK-mediated cancer cells.

Inventors:
KIM BYUNG-HAK (KR)
YE SANG-KYU (KR)
LEE CHUNG GI (KR)
Application Number:
PCT/KR2017/012129
Publication Date:
May 24, 2018
Filing Date:
October 31, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CYTUS H&B CO LTD (KR)
International Classes:
A61K31/4745; A61K9/00; A61K31/437
Domestic Patent References:
WO2015198346A12015-12-30
Foreign References:
US20090062222A12009-03-05
Other References:
ITO, A. ET AL.: "1',2',3',4'-tetradehydrotubulosine, a Cytotoxic Alkaloid from Pogonopus Speciosus", JOURNAL OF NATURAL PRODUCTS, vol. 62, 1999, pages 1346 - 1348, XP055503386
TIETZE, L. F. ET AL.: "Enantioselective Total Syntheses of the Ipecacuanha Alkaloid Emetine, the Alangium Alkaloid Tubulosine and a Novel Benzoquinolizidine Alkaloid by Using a Domino Process", CHEMISTRY-A EUROPEAN JOURNAL, vol. 10, 7 June 2004 (2004-06-07), pages 2722 - 2731, XP055503389
TROCONIS, M. ET AL.: "Molecular Modeling Study of Tubulosine and Other Related Ipecac Alkaloids", JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, vol. 12, 1998, pages 411 - 418, XP055503391
Attorney, Agent or Firm:
YOON, Dae Woong (KR)
Download PDF: